Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to provoke an immune response.
In this chapter, Certara Associate Director of Clinical Pharmacology, Morena Shaw provides an overview of immunogenicity and how to assess it using anti-drug antibody (ADA) Assays.
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/